Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Keratitis, Herpetic | 8 | 2018 | 11 | 2.260 |
Why?
|
| T-Lymphocytes, Regulatory | 6 | 2018 | 219 | 1.710 |
Why?
|
| CD8-Positive T-Lymphocytes | 6 | 2026 | 664 | 1.520 |
Why?
|
| Cornea | 5 | 2018 | 35 | 1.370 |
Why?
|
| Herpes Simplex | 3 | 2018 | 49 | 1.190 |
Why?
|
| Herpesvirus 1, Human | 7 | 2018 | 83 | 1.060 |
Why?
|
| Glucose | 3 | 2019 | 476 | 1.030 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2018 | 241 | 1.010 |
Why?
|
| Tumor Microenvironment | 3 | 2025 | 173 | 0.930 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 165 | 0.920 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2025 | 7 | 0.890 |
Why?
|
| Bile Acids and Salts | 1 | 2025 | 25 | 0.880 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2025 | 51 | 0.860 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2025 | 171 | 0.770 |
Why?
|
| Liver Neoplasms | 1 | 2025 | 304 | 0.720 |
Why?
|
| Neoplasms | 5 | 2026 | 1357 | 0.670 |
Why?
|
| Cellular Microenvironment | 1 | 2020 | 22 | 0.670 |
Why?
|
| Amphiregulin | 1 | 2018 | 3 | 0.570 |
Why?
|
| Receptors, Interleukin-18 | 1 | 2018 | 9 | 0.570 |
Why?
|
| Simplexvirus | 1 | 2018 | 26 | 0.570 |
Why?
|
| Hexokinase | 1 | 2018 | 11 | 0.550 |
Why?
|
| Energy Metabolism | 1 | 2020 | 394 | 0.540 |
Why?
|
| Deoxyglucose | 1 | 2017 | 32 | 0.530 |
Why?
|
| Azacitidine | 1 | 2017 | 15 | 0.520 |
Why?
|
| Encephalitis | 1 | 2017 | 38 | 0.510 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2023 | 636 | 0.510 |
Why?
|
| Inflammation | 3 | 2020 | 1185 | 0.510 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2017 | 88 | 0.510 |
Why?
|
| Viruses | 1 | 2017 | 81 | 0.510 |
Why?
|
| Virus Diseases | 1 | 2017 | 117 | 0.500 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 1007 | 0.500 |
Why?
|
| Mice | 15 | 2026 | 11085 | 0.480 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2017 | 142 | 0.470 |
Why?
|
| Host-Pathogen Interactions | 1 | 2017 | 285 | 0.450 |
Why?
|
| Mice, Inbred C57BL | 9 | 2026 | 3460 | 0.440 |
Why?
|
| Animals | 18 | 2026 | 21292 | 0.410 |
Why?
|
| Lymphocyte Activation | 4 | 2020 | 752 | 0.380 |
Why?
|
| Th1 Cells | 6 | 2023 | 171 | 0.380 |
Why?
|
| Cell Differentiation | 4 | 2026 | 1381 | 0.360 |
Why?
|
| Immunotherapy | 2 | 2025 | 265 | 0.310 |
Why?
|
| Mice, Knockout | 4 | 2018 | 2150 | 0.300 |
Why?
|
| Mitochondria | 2 | 2023 | 399 | 0.270 |
Why?
|
| Cell Line, Tumor | 4 | 2025 | 1556 | 0.260 |
Why?
|
| Programmed Cell Death 1 Receptor | 2 | 2025 | 62 | 0.250 |
Why?
|
| Lithocholic Acid | 1 | 2025 | 1 | 0.220 |
Why?
|
| Th17 Cells | 4 | 2018 | 61 | 0.220 |
Why?
|
| Acyltransferases | 1 | 2025 | 32 | 0.220 |
Why?
|
| Electron Transport Complex II | 1 | 2023 | 3 | 0.210 |
Why?
|
| Electron Transport Complex I | 1 | 2023 | 14 | 0.200 |
Why?
|
| Parasitic Diseases | 1 | 2023 | 5 | 0.200 |
Why?
|
| Hepatocytes | 1 | 2025 | 222 | 0.200 |
Why?
|
| Antigens, Neoplasm | 1 | 2023 | 129 | 0.190 |
Why?
|
| Oxidative Stress | 1 | 2025 | 317 | 0.190 |
Why?
|
| Cells, Cultured | 2 | 2017 | 2188 | 0.190 |
Why?
|
| Tumor Escape | 1 | 2022 | 16 | 0.190 |
Why?
|
| Phagocytosis | 2 | 2023 | 268 | 0.180 |
Why?
|
| Glioblastoma | 1 | 2023 | 159 | 0.180 |
Why?
|
| Receptors, Scavenger | 1 | 2021 | 9 | 0.170 |
Why?
|
| CD36 Antigens | 1 | 2021 | 27 | 0.170 |
Why?
|
| Lipid Peroxidation | 1 | 2021 | 67 | 0.170 |
Why?
|
| Lipoproteins, LDL | 1 | 2021 | 48 | 0.170 |
Why?
|
| Tretinoin | 2 | 2018 | 49 | 0.170 |
Why?
|
| Interleukin-12 | 2 | 2018 | 127 | 0.170 |
Why?
|
| Interleukin-18 | 2 | 2018 | 75 | 0.170 |
Why?
|
| Immunologic Memory | 2 | 2026 | 281 | 0.170 |
Why?
|
| Melanoma | 2 | 2023 | 332 | 0.160 |
Why?
|
| Isotopes | 1 | 2019 | 6 | 0.160 |
Why?
|
| Female | 11 | 2026 | 33739 | 0.150 |
Why?
|
| Metabolomics | 1 | 2019 | 59 | 0.150 |
Why?
|
| Chemokines | 2 | 2017 | 93 | 0.150 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 181 | 0.150 |
Why?
|
| Corneal Stroma | 2 | 2017 | 11 | 0.150 |
Why?
|
| Humans | 10 | 2026 | 64729 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 2 | 2017 | 870 | 0.140 |
Why?
|
| Amyloid | 1 | 2019 | 71 | 0.140 |
Why?
|
| Amyloidosis | 1 | 2019 | 66 | 0.140 |
Why?
|
| Optical Imaging | 1 | 2019 | 77 | 0.140 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 150 | 0.140 |
Why?
|
| Transcription Factors | 1 | 2026 | 1549 | 0.140 |
Why?
|
| Metabolome | 1 | 2017 | 36 | 0.130 |
Why?
|
| Corneal Neovascularization | 1 | 2017 | 2 | 0.130 |
Why?
|
| Docosahexaenoic Acids | 1 | 2017 | 31 | 0.130 |
Why?
|
| Proteomics | 1 | 2019 | 291 | 0.130 |
Why?
|
| Cell Plasticity | 1 | 2017 | 24 | 0.130 |
Why?
|
| Lymphocyte Count | 1 | 2017 | 71 | 0.130 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2017 | 95 | 0.120 |
Why?
|
| Immunity, Cellular | 1 | 2017 | 172 | 0.120 |
Why?
|
| Immunologic Factors | 1 | 2017 | 109 | 0.120 |
Why?
|
| Aspirin | 1 | 2017 | 171 | 0.120 |
Why?
|
| Protective Agents | 1 | 2015 | 12 | 0.120 |
Why?
|
| Virus Replication | 1 | 2017 | 322 | 0.120 |
Why?
|
| Keratitis | 1 | 2015 | 19 | 0.120 |
Why?
|
| Phenotype | 1 | 2019 | 1231 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2017 | 202 | 0.120 |
Why?
|
| Skin Neoplasms | 1 | 2019 | 403 | 0.110 |
Why?
|
| Antiviral Agents | 1 | 2017 | 323 | 0.110 |
Why?
|
| Mutation | 1 | 2022 | 2658 | 0.100 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2015 | 261 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2018 | 2270 | 0.100 |
Why?
|
| Macrophages | 1 | 2019 | 1048 | 0.100 |
Why?
|
| MicroRNAs | 2 | 2017 | 704 | 0.090 |
Why?
|
| Inflammasomes | 1 | 2015 | 346 | 0.090 |
Why?
|
| Signal Transduction | 2 | 2018 | 3147 | 0.080 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2021 | 39 | 0.080 |
Why?
|
| Adoptive Transfer | 2 | 2019 | 145 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 2 | 2018 | 131 | 0.060 |
Why?
|
| Positive Regulatory Domain I-Binding Factor 1 | 1 | 2026 | 9 | 0.060 |
Why?
|
| Atlases as Topic | 1 | 2026 | 13 | 0.060 |
Why?
|
| Down-Regulation | 2 | 2018 | 324 | 0.060 |
Why?
|
| Single-Cell Analysis | 1 | 2026 | 116 | 0.050 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2023 | 5 | 0.050 |
Why?
|
| Anorexia | 1 | 2023 | 4 | 0.050 |
Why?
|
| Electrons | 1 | 2023 | 33 | 0.050 |
Why?
|
| CTLA-4 Antigen | 1 | 2023 | 72 | 0.050 |
Why?
|
| Cachexia | 1 | 2023 | 13 | 0.050 |
Why?
|
| Gene Knockout Techniques | 1 | 2023 | 98 | 0.050 |
Why?
|
| Neutrophils | 2 | 2017 | 394 | 0.050 |
Why?
|
| Methylation | 1 | 2023 | 129 | 0.050 |
Why?
|
| Epigenesis, Genetic | 1 | 2026 | 405 | 0.050 |
Why?
|
| Antigen Presentation | 1 | 2023 | 240 | 0.040 |
Why?
|
| Adipose Tissue | 1 | 2023 | 299 | 0.040 |
Why?
|
| Biological Transport | 1 | 2021 | 292 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2023 | 533 | 0.040 |
Why?
|
| Microglia | 1 | 2023 | 249 | 0.040 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2021 | 246 | 0.040 |
Why?
|
| Histones | 1 | 2023 | 493 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 616 | 0.040 |
Why?
|
| Receptors, Interleukin-6 | 1 | 2018 | 15 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 1285 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 224 | 0.030 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2017 | 24 | 0.030 |
Why?
|
| Chemokine CXCL2 | 1 | 2017 | 16 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 61 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 2017 | 53 | 0.030 |
Why?
|
| Interleukins | 1 | 2017 | 86 | 0.030 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2017 | 65 | 0.030 |
Why?
|
| Homeodomain Proteins | 1 | 2017 | 276 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 231 | 0.030 |
Why?
|
| Inositol Polyphosphate 5-Phosphatases | 1 | 2015 | 8 | 0.030 |
Why?
|
| Receptors, Interferon | 1 | 2015 | 20 | 0.030 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 45 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2015 | 231 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2015 | 273 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 373 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 2603 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 2015 | 226 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 1555 | 0.020 |
Why?
|
| Male | 2 | 2026 | 30790 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2015 | 1029 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1633 | 0.020 |
Why?
|
| Models, Biological | 1 | 2015 | 1203 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 5562 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4771 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2015 | 543 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2019 | 5758 | 0.020 |
Why?
|
| Aged | 1 | 2019 | 14834 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 17230 | 0.010 |
Why?
|
| Middle Aged | 1 | 2019 | 18106 | 0.010 |
Why?
|